Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0010346 (
Crohn's disease
)
21,615
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TNFalpha plays an important role as an inflammatory mediator in both several autoimmune diseases and multiple sclerosis. Anti-TNFalpha antibody has been widely used to treat rheumatoid arthritis and
Crohn's disease
. On the. other hand, anti-TNFalpha antibody treatment increased recurrence rate in clinical trials for multiple sclerosis. We report a patient with rheumatoid arthritis without past history of any neurological disorders, who developed diplopia, ataxia, and visual agnosia specific to line drawing in the course of anti-TNFalpha antibody treatment.
MRI
studies detected multiple demyelinating lesions in the cerebral white matter and brainstem. The present case indicates that careful observation of neurological symptoms is important in the course of anti-TNFalpha antibody treatment, even in patients without past history of demyelinating diseases.
...
PMID:[Apperceptive form visual agnosia caused by anti-TNFalpha therapy to rheumatoid arthritis]. 1751 Dec 76
Recent advances in CT and MR technology, particularly the advent of multidetector CT (MDCT), the advent of rapidly changing gradients in industry standard
MRI
scanners, enabling ultrafast sequences, have led to an expansion in the role of cross sectional imaging in the investigation of small bowel disorders. We conducted an evidence-based review of MR enteroclysis (MRE) and how it performs in comparison to CT enteroclysis (CTE) and the gold standard of conventional enteroclysis (CE) for diagnosis of small bowel
Crohn's disease
and small bowel neoplasia. We used the standard 5 step evidence-based medicine method of ask, search, appraise, apply and evaluate. We found 3 relevant level 1B studies, and one level 3B study. No studies evaluating MRE in small bowel neoplasia were found. MRE does not perform as well as CE in evaluation of fine mucosal detail, but the additional extraluminal detail, and absence of ionising radiation enhances its overall performance. It was not possible to establish the relative diagnostic performances of MRE and CTE from existing literature. CTE does involve patient irradiation. For patients in whom jejunal intubation and enteroclysis is considered to evaluate the small bowel, MRE should be considered the first-line investigation, local resources and expertise permitting.
...
PMID:Magnetic resonance enteroclysis compared with conventional enteroclysis and computed tomography enteroclysis: a critically appraised topic. 1787 64
In a very few years, the video capsule for small bowel enteroscopy has gained widespread clinical acceptance. It is readily ingested, disposable, and allows for a complete, low-invasive endoscopic examination of the entire mucosa of the small bowel. It is a patient-friendly method and a first-line procedure in the difficult evaluation of obscure gastrointestinal bleeding. It has the highest proven figure of diagnostic sensitivity for detecting lesions of the mucosa, irrespective of aetiology. The limitations of capsule endoscopy include difficulty in localising mucosal lesions anatomically and its restricted use in patients with dysphagia, strictures or motor dysfunction. Strictures, transmural and extra-mural lesions in patients with small bowel
Crohn's disease
are evaluated by
MRI
- enterography and CT-enterography.
...
PMID:Capsule enteroscopy and radiology of the small intestine. 1787 83
Over the past two decades there has been considerable evolution in cross-sectional imaging modalities for the evaluation of
Crohn
disease (CD) in children. CT and
MRI
have contributed to conventional techniques so that now radiology has an even greater role in the management of CD, monitoring disease progression and detecting complications. The role of CT and
MRI
, their limitations, and the various imaging features that the radiologist should be aware of are discussed in this review.
...
PMID:CT and MRI of paediatric Crohn disease. 1789 51
To prospectively compare the diagnostic accuracy of MR enteroclysis with duodenal intubation with
MRI
after drinking oral contrast agent only (MR enterography) with conventional enteroclysis (conv-E) as reference standard in patients with
Crohn's disease
. Forty consecutive patients (22 males and 18 females; mean age 36; range 16-74 years) with proven
Crohn's disease
underwent conv-E and MR imaging. Twenty-two patients underwent MR enteroclysis with intubation (MRE) and 18 underwent MR-enterography (MR per OS). Two radiologists reached a consensus about the following imaging findings: luminal distension and visualization of superficial mucosal, mural and mesenteric abnormalities. Standard descriptive statistics and a Wilcoxon rank sum test were used. Statistical significance was inferred at P < 0.05. There was no significant difference in the adequacy of luminal distention between the MRE and conv-E (P = 0.08), and both were statistically superior in comparison to MR per OS in the distension of the jejunum (P < 0.01) and less significant at the ileum and terminal ileum levels (P < 0.05). MRE and conv-E were comparable for the accuracy of superficial mucosal abnormalities; meanwhile conv-E compared with MR per OS was statistically superior (P < 0.01). MRE compared with MR per OS was statistically better when visualizing superficial abnormalities (P < 0.01). No statistically significant differences were found in assessing the diagnostic efficacy between MR examinations for the depiction of mural stenosis (P = 0.105) and fistulae (P = 0.67). The number of detected mesenteric findings was significantly higher with both MRE and MR per OS compared to conv-E (P < 0.01). MRE can serve as the diagnostic procedure for initially evaluating patients suspected of having
Crohn's disease
. MR per OS may have a role in patients that refuse or have failed intubation and also for follow-up.
...
PMID:Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. 1869 Apr 48
Detection of carcinoma in perianal
Crohn's disease
can be difficult. The purpose of this study was to describe the
MRI
appearance of anorectal cancer in patients with perianal
Crohn's disease
. A total of six patients with anorectal carcinoma (four mucinous adenocarcinoma, two squamous) in
Crohn's disease
were retrospectively reviewed. Axial T2 and dynamic postcontrast fat-suppressed T1-weighted gradient echo sequences were performed, and findings were compared with 18 noncancer patients with perianal fistulae in
Crohn's disease
.
MRI
characteristics of carcinoma were irregular inner wall contours and delayed mild enhancement of internal tissue. The combined features of an irregular internal wall and delayed enhancing tissue were seen exclusively in cancer patients. The four cases of mucinous adenocarcinoma all displayed a pattern of lobulated fluid-filled cavities with delayed internal tissue enhancement. This pattern was not seen in any of the control cases. The presence of a double-layered enhancement pattern was seen in both cases of squamous carcinoma and in only one of four cases of mucinous adenocarcinoma and one of 18 noncancer cases. The pattern of contrast enhancement is valuable in the
MRI
diagnosis of carcinoma in perianal
Crohn's disease
.
...
PMID:MRI appearance of perianal carcinoma in Crohn's disease. 1796 42
With recent technological progress,
MRI
can now reliably explore the digestive tract. Gastrointestinal
MRI
can map small intestine involvement in
Crohn
disease, with no irradiation in young patients. In addition,
MRI
provides supporting arguments for inflammatory or fibrous involvement of the intestine.
MRI
of anoperineal fistulae is useful in the preoperative stage to plan surgical treatment so as to reduce the recurrence rate of complex fistulae or recurring fistulae. In rectal cancer,
MRI
is the best examination to evaluate perirectal fascia for choosing neoadjuvant treatment.
...
PMID:[What can be expected from digestive tract MRI?]. 1806 94
A 50-year-old male patient treated with mesalazine for
Crohn's disease
was admitted in our unit for a chest pain, associated with nonspecific ST depression or ECG and troponin elevation. Coronarography showed minimal changes while SPECT imagery suggested a posterobasal subendocardial infarction, so that the diagnosis was unclear between ischemic disease and mesalazine-induced myocarditis. Eventually,
MRI
demonstrated clearly a subendocardial posterior infarction eliciting the diagnosis of mesalazine-induced myocarditis. This case report illustrates, in our opinion, that
MRI
is of invaluable interest in evaluating the characteristics of myocardium, and must be the cornerstone in the diagnosis of myocardial diseases.
...
PMID:[Myocarditis or subendocardial myocardial infarction: role of MRI illustrated by a case report]. 1893 Jan 79
Progressive multifocal leucoencephalopathy (PML) is a rare and often fatal opportunistic infection that has been well reported in patients with rheumatic diseases. The contributions of predisposing factors such as underlying disease and immunosuppressive drug selection are incompletely understood but it would appear that patients with systemic lupus erythematosus may be at highest risk. Natalizumab, a biological agent approved for multiple sclerosis and
Crohn's disease
has the clearest pattern of small but definite risk. Although the risk due to rituximab is difficult to assess given the multiple confounders, continued vigilance is warranted. Rheumatologists need to become familiar with PML and feel able to help patients make shared and informed decisions about the risks when starting treatment with immunosuppressive therapies. In particular, rheumatologists need to be vigilant and pursue the diagnosis of PML in all patients with unexplained neurological signs or symptoms with clinical and
MRI
findings compatible with the diagnosis.
...
PMID:Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. 1902 17
This study was carried out to review our experience with 3-T
MRI
in the assessment of
Crohn
disease in a paediatric population. Twenty-four patients with biopsy proven
Crohn
disease identified on the radiology information system underwent abdominal
MRI
, with or without pelvic
MRI
. Twenty-eight studies were carried out on a 3-T scanner at a tertiary paediatric hospital. Eight of 24 of these (30%) had a gastrointestinal barium study, 2 of 24 (8%) a CT and 9 of 24 (38%) an abdominal ultrasound. The different
MRI
sequences were rated for observation of the bowel wall and abnormalities (0-5). The findings were correlated to relevant findings on endoscopy, examination under anaesthesia (EUA) and where available surgery, barium studies, CT and ultrasound. In this study, the colon was involved in 5 of 28 (18%), small bowel in 7 of 28 (25%), terminal ileum in 5 of 28 (18%). All the perineal studies (9 of 9) showed abnormalities. Sinus tracts or fistulas were identified in 7 of 28 (25%) studies. The mean rating of the different
MRI
sequences in showing bowel wall and changes of
Crohn
disease was T2 TSE 3.6, T2 half fourier aquisition single shot turbo spin echo (HASTE) with a long TE 3.6, T2 HASTE with short TE 3.4, true fast imaging with steady state precession (FISP) 2.7, T1 4.1 and Post-contrast T1 4.3. The T2 HASTE sequences with thinner slices improved observation. Detection of superficial abnormalities was similar on the 3D VIBE images and on the post-contrast T1 spin-echo (SE) sequences. In five of nine (56%) of those that had ultrasound, both studies were abnormal, with incomplete correlation of the abnormalities. Computed tomography and
MRI
were abnormal in two of two (100%) patients with good correlation of the abnormalities in one; in the other there was a minimal discrepancy in the estimation of the length of involved bowel. In 7 of 11 (64%) the barium study was abnormal. Good correlation to
MRI
findings was found in five of seven (71%) of patients. In two of seven (29%) both studies were abnormal, with incomplete correlation of the abnormalities. Barium underestimated the length of involved segment in these patients with inflammatory ileal thickening and ulceration. Notably, in both studies compression was limited because of patient discomfort and the involved segments obscured by overlap. Abdominal and pelvic
MRI
at 3 T is a useful imaging technique for evaluation of
Crohn
disease in the children. The extent of bowel wall involvement and extra-intestinal complications, such as abscesses and fistulas can be accurately assessed non-invasively, without the use of ionizing radiation or sedation.
...
PMID:Imaging for Crohn disease: use of 3-T MRI in a paediatric setting. 1903 94
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>